Ozempic: Luxury or Lifesaver — Should Taxpayers Foot the Bill?

From the skyrocketing costs of drugs like Ozempic and Wegovy to the moral and economic debate over obesity as a disease, Michael explores both sides of this billion-dollar question: "Should Congress mandate Medicaid to cover weight-loss medications like GLP-1s?" Listen to his take, then vote on today's poll at smerconish.com. He also revisits yesterday's poll question on the political buzz around Kamala Harris, Gavin Newsom, and the 2028 race — plus some media mayhem from New York’s mayoral contest. Please rate, review, and share this podcast. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.